AI assistant
Sending…
STRATA Skin Sciences, Inc. — Director's Dealing 2011
Jul 22, 2011
35146_dirs_2011-07-22_02e476e2-2942-4cff-a8c5-41f6d1b70ad2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MELA SCIENCES, INC. /NY (MELA)
CIK: 0001051514
Period of Report: 2011-05-23
Reporting Person: Kabelev Nikolai (V.P. of R&D)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-05-23 | Stock Option | $3.05 | A | 90000 | Acquired | 2021-05-23 | Common Stock (90000) | Direct |
Footnotes
F1: On May 23, 2011 90,000 options were granted of which 60,000 options shall vest immediately and the remaining 30,000 options shall vest upon PMA approval from the United States Food and Drug Administration.
More from STRATA Skin Sciences, Inc.
Regulatory Filings
2026
Feb 11
Regulatory Filings
2025
Dec 17
Regulatory Filings
2025
Dec 10
Director's Dealing
2025
Nov 18
Interim / Quarterly Report
2025
Nov 14
Regulatory Filings
2025
Nov 13
Major Shareholding Notification
2025
Nov 7
Proxy Solicitation & Information Statement
2025
Oct 30
Regulatory Filings
2025
Oct 20
Regulatory Filings
2025
Oct 16